A Case of Sub-Diaphragmatic Abscess after Injection of Botulinum Toxin to Treat Achalasia

Achalasia is a disorder of the esophagus characterized by decreased lower esophageal sphincter (LES) relaxation and absence of esophageal peristalsis. Botulinum toxin (BT) injection targeting the LES has been used in the treatment of achalasia and other esophageal motility disorders, and it is consi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fisher, Constantine, Puello, Frances, Ferm, Samson, Rubin, Moshe, Schnall, H. Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Gastroenterology 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703760/
https://www.ncbi.nlm.nih.gov/pubmed/29201930
http://dx.doi.org/10.14309/crj.2017.119
Descripción
Sumario:Achalasia is a disorder of the esophagus characterized by decreased lower esophageal sphincter (LES) relaxation and absence of esophageal peristalsis. Botulinum toxin (BT) injection targeting the LES has been used in the treatment of achalasia and other esophageal motility disorders, and it is considered to be safe and effective for short-term symptomatic relief. Serious adverse events of this procedure are rare. We report the case of an 83-year-old woman treated with BT injection for achalasia who subsequently developed a subdiaphragmatic abscess.

Ejemplares similares